Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123429452 | 12342945 | 2 | F | 20160817 | 20160506 | 20160826 | EXP | CA-AMGEN-CANSP2016055450 | AMGEN | 60.00 | YR | A | F | Y | 0.00000 | 20160826 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123429452 | 12342945 | 1 | PS | ENBREL | ETANERCEPT | 1 | Subcutaneous | 25 MG, 2 TIMES/WK | U | 103795 | 25 | MG | UNKNOWN FORMULATION | BIW | |||||
| 123429452 | 12342945 | 2 | SS | GOLD | GOLD | 1 | Unknown | UNK | 0 | INJECTION | |||||||||
| 123429452 | 12342945 | 3 | SS | IMURAN | AZATHIOPRINE | 1 | Unknown | UNK | 0 | ||||||||||
| 123429452 | 12342945 | 4 | SS | KINERET | ANAKINRA | 1 | Unknown | UNK | 0 | ||||||||||
| 123429452 | 12342945 | 5 | SS | LEFLUNOMIDE. | LEFLUNOMIDE | 1 | Unknown | UNK | 0 | TABLET | |||||||||
| 123429452 | 12342945 | 6 | SS | METHOTREXATE. | METHOTREXATE | 1 | Unknown | UNK | 0 | ||||||||||
| 123429452 | 12342945 | 7 | SS | PLAQUENIL | HYDROXYCHLOROQUINE SULFATE | 1 | Unknown | UNK | 0 | TABLET | |||||||||
| 123429452 | 12342945 | 8 | SS | REMICADE | INFLIXIMAB | 1 | Intravenous (not otherwise specified) | UNK | 0 | ||||||||||
| 123429452 | 12342945 | 9 | SS | RITUXAN | RITUXIMAB | 1 | Intravenous (not otherwise specified) | UNK | 0 | ||||||||||
| 123429452 | 12342945 | 10 | SS | ANAKINRA | ANAKINRA | 1 | Subcutaneous | UNK | 0 | ||||||||||
| 123429452 | 12342945 | 11 | SS | HYDROXYCHLOROQUINE | HYDROXYCHLOROQUINE | 1 | Unknown | UNK | 0 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123429452 | 12342945 | 1 | Rheumatoid arthritis |
| 123429452 | 12342945 | 2 | Rheumatoid arthritis |
| 123429452 | 12342945 | 3 | Rheumatoid arthritis |
| 123429452 | 12342945 | 4 | Rheumatoid arthritis |
| 123429452 | 12342945 | 5 | Rheumatoid arthritis |
| 123429452 | 12342945 | 6 | Rheumatoid arthritis |
| 123429452 | 12342945 | 7 | Rheumatoid arthritis |
| 123429452 | 12342945 | 8 | Rheumatoid arthritis |
| 123429452 | 12342945 | 9 | Rheumatoid arthritis |
| 123429452 | 12342945 | 10 | Rheumatoid arthritis |
| 123429452 | 12342945 | 11 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123429452 | 12342945 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123429452 | 12342945 | Drug ineffective | |
| 123429452 | 12342945 | Joint swelling |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |